Efficacy and Safety Deep Dive What Latest Data Tell Us
Christie Ballantyne, MD
Advancing Lipid Care: CETP Inhibition and Overcoming Inertia in Modern ASCVD Management
Erin Michos
Philip Scheltens, MD, PhD
What Comes Next: Building the Future Lipid Toolbox
Beyond Lipids: Metabolic and Renal Implications of CETP Inhibition
Beyond LDL-C: Genetic Drivers of Residual Risk in ASCVD
Personalized Treatment Strategies for Hyperkalemia: Bridging Evidence and Clinical Practice Needs
Ellie Kelepouris, MD, FACP, FAHA
Differentiating Oral Potassium Binders: Mechanism, Onset, and Sodium Load
James Burton, DM, FRCP
From Lab Alert to Action Plan: Monitoring Potassium Without Undermining Cardiorenal Protection
Pauline A. Swift, PhD
Potassium Binders to Optimize GDMT Therapy in HFrEF
Nihar R. Desai, MD, MPH
The Binder Selection Playbook: Matching the Right Strategy to the Right Patient
From Episode to Empowerment
Jennifer Carlquist, PA-C
Brian P. Rose, PA-C, MPH
How to Build a Standardized Episode Algorithm
Sean Pokorney, MD, MBA
Ambulatory Monitoring Approaches for PSVT: Which One and When?
Improving Outcomes in PSVT: Best Practices for Choosing Optimal Management Strategies
Applying Best Practices in the Diagnosis of PSVT
Proteinuria in IgAN: The Signal, The Target, and the Treatment Goal
Jonathan Barratt, MD, PhD
An De Vriese, MD, PhD